品牌	货号	产品规格	价格(RMB)	库存（上海）	北京	武汉	南京	购买数量
源叶(MedMol)	S81014-100mg	99%	￥370.00元	1	-	-	-
源叶(MedMol)	S81014-500mg	99%	￥1300.00元	预计交期：2-3天	-	-	-

产品介绍

Mirtazapine (Org3770) is a potent and orally active noradrenergic and specific serotonergic antidepressant (NaSSA) agent. Mirtazapine is also a 5-HT2, 5-HT3, histamine H1 receptor and α2-adrenoceptor antagonist with pKi values of 8.05, 8.1, 9.3 and 6.95, respectively

产品描述： Mirtazapine (Org3770) is a potent and orally active noradrenergic and specific serotonergic antidepressant (NaSSA) agent. Mirtazapine is also a 5-HT2, 5-HT3, histamine H1 receptor and α2-adrenoceptor antagonist with pKi values of 8.05, 8.1, 9.3 and 6.95, respectively

靶点： 5-HT3 Receptor:8.1 (pKi);5-HT2 Receptor:8.05 (pKi);H1 Receptor:9.3 (pKi);α2-adrenergic receptor:6.95 (pKi);DopamineReceptor; 5-HTReceptor; OpioidReceptor; AdrenergicReceptor; HistamineReceptor

体外研究：
Mirtazapine can antagonize the adrenergic α2-autoreceptors and α2-heteroreceptors as well as block 5-HT2 and 5-HT3 receptors. Mirtazapine enhances the release of norepinephrine and 5-HT1A-mediated serotonergic transmission. The cytochrome (CYP) P450 isoenzymes CYP1A2, CYP2D6, and CYP3A4 are mainly responsible for Mirtazapine's metabolism. Mirtazapine (10 μM) significantly reduces activation-induced release of cytokine/chemokine mediators from human CD14+ monocytes in vitro

体内研究：
Mirtazapine (1-20 mg/kg; intraperitoneal injection; once; C57BL/6 mice) treatment strikingly and dose-dependently inhibits Con A-induced liver injury. Mirtazapine treatment inhibits hepatic macrophage/monocyte activation, decreases hepatic macrophage/monocyte-derived pro-inflammatory cytokine (e.g., TNFα) and chemokine (e.g., CXCL1 and CXCL2) production, suppression of Con A-induced increases in the hepatic expression of the neutrophil relevant endothelial cell adhesion molecule ICAM-1, with the resultant significant reduction in neutrophil recruitment into the liver. Animal Model: Male C57BL/6 mice (8-10 week old) treated with concanavalin A (Con A) Dosage: 1 mg/kg, 10 mg/kg, and 20 mg/kg Administration: Intraperitoneal injection; once Result: Strikingly and dose-dependently inhibited Con A-induced liver injury.

参考文献：
1. S A Anttila, et al. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. Fall 2001;7(3):249-64. 2. T H de Boer, et al. Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology. 1988 Apr;27(4):399-408. 3. Wagdi Almishri, et al. The Antidepressant Mirtazapine Inhibits Hepatic Innate Immune Networks to Attenuate Immune-Mediated Liver Injury in Mice. Front Immunol. 2019 Apr 12;10:803.

溶解性： Soluble in DMSO、H2O

保存条件： -20℃

配置溶液浓度参考：

	1mg	5mg	10mg
1 mM	3.769 ml	18.843 ml	37.686 ml
5 mM	0.754 ml	3.769 ml	7.537 ml
10 mM	0.377 ml	1.884 ml	3.769 ml
50 mM	0.075 ml	0.377 ml	0.754 ml

注意：

部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。

参考文献

质检证书(COA)

输入产品批号：

如何获取质检证书(COA)?

请输入货号和一个与之匹配的批号。
例如:
批号：C10000001 货号：A800001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

质量

浓度

体积

分子摩尔量

计算重置

产品中心

Product center

Mirtazapine 99%

Mirtazapine